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ThObjective: Nonliving synthetic materials have been widely used to repair myocardial
defects; however, material-related failures do occur. To overcome these problems,
an acellular bovine pericardium with a porous structure fixed with genipin (the AGP
patch) was developed.
Methods: The AGP patch was used to repair a surgically created myocardial defect
in the right ventricle of a rat model. A commercially available expanded polytet-
rafluoroethylene (e-PTFE) patch was used as a control. At retrieval, a computerized
mapping system was used to acquire local epicardial electrograms of each implanted
sample, and the appearance of each retrieved sample was grossly examined. The
retrieved samples were then processed for histologic examination.
Results: The amplitude of local electrograms on the AGP patch increased signifi-
cantly with increasing implantation duration, whereas only low-amplitude electro-
grams were observed on the e-PTFE patch throughout the entire course of the study.
No aneurysmal dilation of the implanted patches was seen for either studied group.
Additionally, no tissue adhesion was observed on the outer (epicardial) surface of
the AGP patch, whereas a moderate tissue adhesion was observed on the e-PTFE
patch. On the inner (endocardial) surface, intimal thickening was observed for both
studied groups; however, no thrombus formation was found. Intact layers of endo-
thelial and mesothelial cells were identified on the inner and outer surfaces of the
AGP patch, respectively. At 4 weeks postoperatively, smooth muscle cells, together
with neomuscle fibers (with a few neocollagen fibrils), neoglycosaminoglycans, and
neocapillaries, were observed to fill the pores in the AGP patch, an indication of
tissue regeneration. These observations were more pronounced at 12 weeks post-
operatively. In contrast, no apparent tissue regeneration was observed in the e-PTFE
patch.
Conclusion: The present study indicated that the AGP patch holds promise to
become a suitable patch for surgical repair of myocardial defects.
Clinically, human myocardium lacks the possibility of regeneration. Thisresults in a progressive loss of functional myocardium and a successivereduction in cardiac performance.1 A patch is often mandatory to repair
failing myocardium or congenital cardiac malformations.2 Currently, the patches
used clinically are made of Dacron polyester fabric, polytetrafluoroethylene (PTFE),
glutaraldehyde-treated bovine pericardium, or antibiotic-preserved or cryopreserved
homografts.3 However, the long-term results have been compromised by material-
related failures because these materials are not viable, do not grow, and do not
provide pulsate flow.3
Courtman and colleagues4 developed a cell-extraction process to render bovine
pericardia free of cells. They hypothesized that cell extraction might remove cellular
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tissues have been proposed to be used as natural biomate-
rials for tissue repair and tissue engineering.4,5 Natural
biomaterials are composed of extracellular matrix proteins
that are conserved among different species and that can
serve as scaffolds for cell attachment, migration, and pro-
liferation.5 This can be a large advantage over synthetic
materials.
Our previous study found that the acellular bovine peri-
cardial tissue fixed with genipin can provide a natural mi-
croenvironment for host cell migration and might be used as
a tissue-engineering extracellular matrix to accelerate tissue
regeneration.5 Genipin, a naturally occurring cross-linking
agent, can be obtained from its parent compound, genipo-
side, which can be isolated from the fruits of Gardenia
jasminoides Ellis.6 It has been used to fix biologic tissues or
amino groups containing biomaterials for biomedical appli-
cations.6 It was found that genipin is significantly less
cytotoxic than glutaraldehyde.7,8 In this study an acellular
bovine pericardium with a porous structure fixed by genipin
was prepared and used to repair a surgically created myo-
cardial defect in the right ventricle of a rat model.
Materials and Methods
Preparation of Test Samples
The procedures used to remove the cellular components from
bovine pericardia were based on a method previously reported by
Courtman and colleagues,4 with slight modifications. To increase
the pore size and porosity within test samples, the acellular tissues
were treated additionally with acetic acid and subsequently with
collagenase.9,10 Finally, the acellular tissues with a porous struc-
ture were fixed in a 0.05% genipin (Challenge Bioproducts, Tai-
wan) aqueous solution (phosphate-buffered saline, pH 7.4) at 37°C
for 3 days.
The degree of cross-linking of the genipin-fixed porous acel-
lular bovine pericardium (the AGP patch) was determined by
measuring its fixation index and denaturation temperature (n 
5).11 The fixation index, determined by the ninhydrin assay, was
defined as the percentage of free amino groups in test tissues
reacted with genipin subsequent to fixation. After preparation of
test samples, the AGP patch was processed for light microscopic
and scanning electron microscopic examinations to investigate its
ultrastructures.12 The pore size of the AGP patch, stained with
hematoxylin and eosin (H&E), was determined with a microscope.
The porosity of the AGP patch was measured by helium pycnom-
etery.13 Mechanical testing of the AGP patch was conducted by an
Instron material testing machine (Mini 44, Canton, Mass).14
The prepared AGP patch was sterilized in a graded series of
ethanol solutions for the animal study. A commercially available
expanded PTFE (e-PTFE) patch (Gore-Tex patch; W. L. Gore &
Associates, Inc, Flagstaff, Ariz) was used as a control.
Animal Study
Animal care and use was performed in compliance with the “Guide
for the Care and Use of Laboratory Animals” prepared by the
Institute of Laboratory Animal Resources, National Research
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1996. The studied patches (7.0  7.0 mm) were used to repair
transmural defects surgically created in the right ventricles of rat
hearts (male S. D. rats, National Laboratory Animal Centers,
Taiwan; weight, 400-450 g) on the basis of a method reported by
Ozawa and associates.15 The implanted samples were retrieved at
4 and 12 weeks postoperatively (n  5 rats for the AGP patch and
n  3 rats for the e-PTFE patch at each time point) and were used
for histologic examination.
Computerized Mappings (Epicardial Electrograms)
In this study a CardioMap mapping system with a plaque electrode
array (Prucka Engineering, Houston, Tex) was used to acquire the
epicardial electrograms of the implanted patch and its adjacent rat
native myocardium immediately after implantation and at retrieval.
The plaque electrode array consisted of 112 bipolar electrodes (a 7
 16 array spanning across a 2.2  6.0–cm rectangular surface)
with an interelectrode distance of 3.0 mm.16 The implanted sam-
ples were then retrieved, and the appearance of each retrieved
sample was grossly examined and photographed.
Histologic Examinations
The samples used for light microscopy were fixed in 10% phos-
phate-buffered formalin and prepared for histologic examination.
In the histologic examination the fixed samples were embedded in
paraffin, sectioned to a thickness of 5 m, and then stained with
H&E. Also, sections of test samples were stained with Masson
trichrome and elastic van Gieson (EVG) for the detection of
collagen fibrils and muscle fibers and stained with safranin-O to
visualize glycosaminoglycans. Additional sections were stained
with a van Gieson solution to visualize mesothelial cells.17
Immunohistologic staining of smooth muscle cells was per-
formed on deparaffinized sections with a monoclonal antibody
against -smooth muscle actin (-SMA; DAKO Corp, Carpinteria,
Calif) and revealed by a peroxidase-antiperoxidase technique.18
Five different microscopic fields (400 by ECLIPSE-E800; Ni-
kon, Tokyo, Japan) of each patch portion of the right ventricular
wall were randomly selected. The area of each studied patch
staining positively for -SMA per microscopic field area was
counted with a computer-based image-analysis system (Image-Pro
Plus; Media Cybernetics, Silver Spring, Md) and converted to
percentages.15,19 Additionally, the depth of cells positively stained
with a monoclonal antibody against -SMA (-SMA–positive
cells) infiltrated into each studied patch was quantified with the
same image-analysis system (as a percentage of the depth of the
whole test sample).19 Additional sections were stained for factor
VIII with immunohistologic technique with a monoclonal anti-
factor VIII antibody (DAKO).20
Results
Test Samples
The bovine pericardium before cell extraction showed a
number of intact cells embedded within the connective
tissue matrix (Figure E1 a), whereas the acellular bovine
pericardium treated with acetic acid revealed large open
spaces (pores; Figure E1, c). After additional treatment with
collagenase (Figure E1, b and d), the pores in the acellular
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increased interconnectivity. The pore size and porosity of
the AGP patch were 159.8  26.7 m and 94.9%  1.7%,
respectively, whereas its denaturation temperature and fix-
ation index were 75.5°C  0.3°C and 57.8%  5.4%,
respectively (n  5). The ultimate tensile strength of the
AGP patch was 2.1  0.3 MPa (n  5).
Computerized Mappings (Epicardial Electrograms)
Immediately after implantation, low-amplitude electrogram
signals were observed on both the e-PTFE and AGP patches
(Figure 1, b and h). At 4 and 12 weeks postoperatively, the
mappings of the epicardial electrograms on the e-PTFE
patch still showed low amplitudes compared with those
observed on its adjacent native myocardium (Figure 1, d and
f). In contrast, the amplitude of the local electrograms on the
epicardial surface of the AGP patch increased significantly
with increasing implantation duration (Figure 1, j and l).
Gross Examination
At retrieval, on the outer surface, no apparent tissue adhe-
sion was observed on the AGP patch for all the animals
studied, whereas a moderate adhesion to the chest wall was
seen for the e-PTFE patch in one of the animals studied (n
 3 at each time point). On the inner surface, intimal
thickening was observed for both studied groups; however,
no thrombus formation was found. No aneurysmal dilation
of the implanted patches was seen for either studied group
throughout the entire course of the study.
Histologic Findings
At 4 weeks postoperatively, intimal thickening was ob-
served on the inner surfaces of both studied groups (Figure
E2,a and b). Host cells, together with neotissue fibrils and
neocapillaries, were clearly observed in the inner and outer
layers of the AGP patch (Figure e2, b and d). In contrast,
only a few infiltrated cells (mostly inflammatory cells) were
found in the innermost and outermost layers of the e-PTFE
patch (Figure e2, a and c). Endothelial-like cells were
visible on the inner surfaces of both studied groups (Figure
e2, a and b). Additionally, mesothelial-like cells were ob-
served on the outer surface of the AGP patch (Figure E2, d).
However, no mesothelial-like cells were found on the outer
surface of the e-PTFE patch (Figure E2, c). Instead, fibrous
tissue was firmly attached to the outer surface of the e-PTFE
patch.
Degradation of the structural fibrils (collagen network) in
the AGP patch was observed. Additionally, host cells, to-
gether with neotissue fibrils, were found to fill some of the
pores in the middle layer of the AGP patch (Figure E3, b).
In contrast, no apparent degradation was observed for the
e-PTFE patch, and neither cells nor neotissue fibrils were
observed in the e-PTFE patch (Figure E3, a). The neotissue
The Journal of Thoracic afibrils regenerated in the AGP patch were identified to be
neomuscle fibers (stained red) with a few neocollagen fibrils
(stained blue), as determined with Masson trichrome stain
(Figure E3, d). The neomuscle fibers seen in the AGP patch
were further confirmed with EVG stain (stained brown,
Figure E3, f). Also, there were some neoglycosaminogly-
cans regenerated within the pores of the AGP patch recog-
nized by safranin-O stain (stained pink; Figure E3, h).
An intact layer of endothelial cells was identified on the
intimal thickening generated on the inner (endocardial) sur-
face of the AGP patch by the factor VIII staining (Figure 2,
B). In contrast, endothelial cells did not universally and
totally cover the entire inner surface of the e-PTFE patch
(Figure 2, a). The outer surface of the AGP patch was
positively stained with van Gieson stain (Figure 2, d),
indicating the presence of mesothelial cells. However, no
mesothelial cells were observed on the outer surface of the
e-PTFE patch (Figure 2, c). Additionally, -SMA positively
stained cells were observed in the middle layer of the AGP
patch (Figure 2, f).
At 12 weeks postoperatively, there were still no signs of
tissue regeneration (host cells and neotissue fibrils) ob-
served inside the e-PTFE patch (Figure 3, a, c, and e).
Compared with those observed at 4 weeks postoperatively,
a more apparent degradation in the structural fibrils of the
AGP patch was found (Figure 3, b), whereas the neomuscle
fibers seen were more compact and organized (Figure 3, d).
The area of cells positively stained with a monoclonal
antibody against -SMA in the AGP patch (24.5%  3.2%
of the entire patch; Figure 3, f) appeared to be larger than
that observed at 4 weeks postoperatively (9.0%  2.0%;
Figure 2, f). Additionally, the depth of the -SMA–positive
cells infiltrated into the AGP patch (98.7%  2.6%) was
significantly greater than its counterpart found at 4 weeks
postoperatively (57.8%  7.9%).
Discussion
We found that the e-PTFE and AGP patches did not thin and
dilate as a patch to repair a myocardial defect created in the
right ventricle of a rat model throughout the entire course of
the study. This indicated that the mechanical strengths of
both studied groups were strong enough to tolerate the right
ventricular pressure without aneurysmal dilation during the
long-term implantation. The e-PTFE patch has been ac-
cepted worldwide as one of the most reliable nondegradable
synthetic materials in terms of durability, low thromboge-
nicity, and comfortable handling for surgical intervention.21
Additionally, an advantage of the e-PTFE patch is that it
does not thin and dilate in response to intraventricular
pressure.15 Unfortunately, the e-PTFE patch is not viable,
does not provide pulsatile flow, and does not grow as a
child’s heart or blood vessel grows.22
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the AGP patch retrieved at 4 weeks postoperatively became
well integrated with the host tissue, as shown by our histo-
logic examination. (Host cells, together with neotissue
fibrils and neocapillaries, were noted in the outer layer of
the AGP patch.) Additionally, there was an intact layer of
neomesothelial cells, identified by using the van Gieson
stain, observed on the outer surface of the AGP patch
(Figure 2, d). However, such observations did not occur in
or on the e-PTFE patch (Figure E2, c, and Figure 2, c).
Instead, fibrous tissue was firmly attached to the outer
surface of the e-PTFE patch. It is known that the epicardium
forms the outer covering of the heart and has an external
705.e4 The Journal of Thoracic and Cardiovascular Surgery ● Selayer of flat mesothelial cells.23 It is well documented that
mesothelial cells prevent adhesions.24 Whitaker and co-
workers24 reported that a pure culture of mesothelial cells
was able to induce fibrinolysis. These results likely explain
the observation that once the surface of the AGP patch was
populated with mesothelial cells, it remained resistant to
adhesion formation.
At 4 weeks postoperatively, intimal thickening covered
with endothelial cells was found on the inner (endocardial)
surfaces of the e-PTFE and AGP patches. This finding
suggested that host endocardial endothelial cells or endo-
thelial progenitor cells were involved in the endothelializa-
Figure 1. Local electrograms obtained
from the electrodes located on the epi-
cardial surfaces of the e-PTFE and AGP
patches and their adjacent rat native
myocardia immediately after implanta-
tion and those observed at 4 and 12
weeks postoperatively. a and b, e-PTFE
immediately after implantation; c and
d, e-PTFE at 4 weeks postoperatively; e
and f, e-PTFE at 12 weeks postopera-
tively; g and h, AGP immediately after
implantation; i and j, AGP at 4 weeks
postoperatively; k and l, AGP at 12
weeks postoperatively.tion on the inner surfaces of the implanted patches.3,25 No
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Similar results were also observed in our previous study in
using the genipin-fixed acellular bovine pericardium as a
patch to repair a defect created in the pulmonary trunk in a
canine model.26
As indicated by the H&E, Masson trichrome, EVG, and
safranin-O stains (Figure E3, b, d, f, and h), host cells,
together with neomuscle fibers (with a few neocollagen
fibrils), neoglycosaminoglycans, and neocapillaries, were
observed to fill the pores in the AGP patch at 4 weeks
postoperatively, an indication of tissue regeneration. Addi-
tionally, the middle layer of the AGP patch was positively
stained with a monoclonal antibody against -SMA (Figure
2, f, and Figure 3, f), indicating that myofibroblasts or
smooth muscle cells were observed in the AGP patch. It is
known that myofibroblasts show an immunohistochemical
Figure 2. Photomicrographs of the e-PTFE and AGP patches stained
with an antibody against factor VIII (a and b: original magnification,
800), van Gieson (c and d: original magnification, 800), and a
monoclonal antibody against -SMA (e and f: original magnification,
400) retrieved at 4 weeks postoperatively.expression of -SMA.27 Collagen synthesis might be one of
The Journal of Thoracic athe important roles of myofibroblasts, supplementing the
damaged area where the parenchymal tissue is defective
(scar formation).27,28
On the other hand, smooth muscle cells permit formation
of a muscular tissue (observed in our AGP patch: stained
red with Masson trichrome, Figure E3, d, and Figure 3, d;
stained brown with EVG, Figure E3, f) in addition to col-
lagen formation (stained blue with Masson trichrome).29
Therefore, the -SMA–positive cells observed in the AGP
patch appeared to be smooth muscle cells (Figure 2, f, and
Figure 3, f) rather than myofibroblasts. Accordingly, migra-
tion of smooth muscle cells into the AGP patch occurred
and resulted in artificial muscle-like tissues.30 This finding
suggested that host progenitor cells from the systemic cir-
culation or from the surrounding tissue might be relevant to
the presence of smooth muscle cells in the AGP patch.25
The aforementioned observations were more pronounced at
Figure 3. Photomicrographs of the middle layers of the e-PTFE
and AGP patches stained with H&E (a and b), Masson trichrome
(c and d), and a monoclonal antibody against -SMA (e and f)
retrieved at 12 weeks postoperatively. (Original magnification,
400.)12 weeks postoperatively (Figure 3, b, d, and f).
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cell–seeded biodegradable patches can be used to repair the
right ventricular outflow tract. The seeded smooth muscle
cells survived in scaffolds for 8 weeks and led to new
muscular formation. In their study the smooth muscle cells
were chosen because they can be harvested from a number
of sources in the donor and returned to the donor as an
autologous cell patch. It was reported that smooth muscle
cells can respond to in vivo mechanical stress by hyperpla-
sia and hypertrophy to prevent patch dilation and thinning
and improve myocardial function.30 Additionally, it is
known that smooth muscle cells are one of the specialized
contractile cell types distinguished in the human body.31 An
autologous, cell-seeded, biodegradable patch might pre-
serve the structure of the ventricular wall while providing
the potential for growth and contractility.
In contrast, only a few infiltrated inflammatory cells were
present in the most outer and inner layers of the e-PTFE
patch (Figure E2, a and c). Also, no apparent tissue regen-
eration was observed in the middle layer of the e-PTFE
patch (Figure E3, a, c, e, and g, and Figure 3, a, c, and e),
whereas only low-amplitude electrogram signals were ob-
served on the epicardial surface of the e-PTFE patch
throughout the entire course of the study (Figure 1, d and f).
On the contrary, the amplitude of the local electrograms on
the AGP patch increased significantly with increasing im-
plantation duration (Figure 1, j and l), an indication of better
electrical conductance. The increase in the amplitude of the
local electrograms on the AGP patch might be due to the
regenerated tissues observed in its pores.
In this study, smooth muscle cells, together with neo-
muscle fibers, were observed in the AGP patch, an indica-
tion of tissue regeneration. However, cardiomyocytes were
not found within the AGP patch, a significant limitation of
this study. In a future study, we plan to seed bone marrow
mesenchymal stem cells onto the AGP patch. It was re-
ported that autologous bone marrow cells transplanted into
ventricular scar tissue might differentiate into cardiomyo-
cytes and restore myocardial function.32 The main benefits
of the cardiomyocytes are thought to be an increase in
myocardial wall tension and elasticity, which minimize
ventricular dilation.33
Conclusions
In conclusion, the AGP patch might preserve the structure
of the right ventricle and prevent aneurysmal dilation while
providing the potential for tissue regeneration. These results
indicated that the AGP patch holds promise to become a
suitable patch for surgical repair of myocardial defects.
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Cardiopulmonary Support and Physiology Chang et alFigure E1. Photomicrographs of the bovine pericardium before cell extraction (a) and the prepared AGP patch (b),
with the acellular bovine pericardium additionally treated with acetic acid, subsequently treated with collage-
nase, and stained with H&E (original magnification, 200), and scanning electron microscopic micrographs of the
acellular bovine pericardium treated with acetic acid (c) and further treated with collagenase (d; the AGP patch).705.e8 The Journal of Thoracic and Cardiovascular Surgery ● September 2005
Chang et al Cardiopulmonary Support and PhysiologyFigure E2. Photomicrographs of the inner (endocardial) layers of the e-PTFE patch (a) and the AGP patch (b) and
the outer (epicardial) layers of the e-PTFE patch (c) and the AGP patch (d) stained with H&E retrieved at 4 weeks
postoperatively. (Original magnification 200.)The Journal of Thoracic and Cardiovascular Surgery ● Volume 130, Number 3 705.e9
Cardiopulmonary Support and Physiology Chang et alFigure E3. Photomicrographs of the middle layers of the e-PTFE and AGP patches stained with H&E (a and b:
original magnification 400), Masson trichrome (c and d: original magnification 400), EVG (e and f: original
magnification 400), and safranin-O (g and h: original magnification 200) retrieved at 4 weeks postoperatively.705.e10 The Journal of Thoracic and Cardiovascular Surgery ● September 2005
